Investigating the role of double-stranded RNA in early gastric cancer development
The double-stranded RNA (dsRNA) response in gastric pre-neoplasia
This study is looking at how certain signals in the stomach might play a role in the early stages of gastric cancer, especially a condition called pyloric metaplasia, and it aims to find new ways to prevent this type of cancer by using specially modified mice to understand the process better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11022662 on NIH RePORTER |
What this research studies
This research focuses on understanding how double-stranded RNA (dsRNA) signaling contributes to the early stages of gastric cancer, particularly in the development of pyloric metaplasia, a pre-cancerous condition. The researchers will explore the mechanisms by which dsRNA accumulates in gastric tissues and how it may influence inflammation and tumor formation. By studying genetically modified mice, they aim to identify key pathways that could be targeted for therapeutic intervention. This work could provide insights into new strategies for preventing gastric cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic gastric inflammation or those at high risk for developing gastric cancer.
Not a fit: Patients with established gastric cancer or those without any history of gastric issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new prevention strategies for gastric cancer, potentially reducing its incidence and improving patient outcomes.
How similar studies have performed: While the role of dsRNA in other cancers has been explored, this specific investigation into gastric pre-neoplasia is relatively novel and untested.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Saenz, Jose Bernardo — Washington University
- Study coordinator: Saenz, Jose Bernardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.